Kantar Health to Present at Market Access Europe 2010

NEW YORK, February 23, 2010 - Kantar Health, a leading healthcare-focused global consultancy, today
announced that Natalie Shalet, Senior Consultant, Treatment Value, will
present at eyeforpharma's Market Access Europe 2010 Conference. The
conference will take place March 2-3, 2010, at the Regent's Park Marriott
Hotel in London.

Ms. Shalet's presentation, titled "Cost Containment: Variations Within
and Among EU Countries," will discuss:

    - The role pricing plays in politics
    - How innovative risk-sharing schemes improve the value proposition of
      high-priced therapies
    - The power of value demonstration solutions-utilize effective ways to
      identify, measure, and show value of the product

The presentation is recommended for market access managers, pricing
managers, marketing and international brand managers, and market researchers.

"EU governments face the daunting task of maintaining nearly universal
coverage in this era of rising treatment costs," Ms. Shalet said.
"Cost-containment measures vary from brute force methods, such as mandated
price cuts, to risk-sharing schemes that improve a therapy's value
proposition but at a cost of administrative complexity. The most effective
concepts are migrating not only among various EU markets but also between the
United States and the EU."

Ms. Shalet has worked as a Clinical Research Associate focusing on
oncology trials based in Europe, then in finance in Mergers and Acquisitions
doing IPOs for small Pharma and biotech companies and looking at acquisition
targets for clients. Ms. Shalet's academic background is in science,
specifically biological sciences. Ms. Shalet completed a B.S. in Molecular
Cell Biology and a Master's in Clinical Oncology, both at the University of
Nottingham.

Kantar Health is a Global Sponsor for Market Access Europe 2010. For more
information on this conference, please visit
www.eyeforpharma.com/marketaccesseurope/index.shtml.

About Kantar Health

Kantar Health is a leading healthcare-focused global consultancy,
specializing in portfolio optimization, market access, safety and outcomes,
and brand and customer insights. Formed by uniting Consumer Health Sciences,
MattsonJack, TNS Healthcare and Ziment, it is the next- generation decision
support partner to the pharmaceutical and biotech industries, delivering
evidence-based guidance to support clients' global and local success.

With 40+ offices throughout the Americas, Europe, Asia-Pacific, the
Middle East and Africa, Kantar Health provides the broadest global footprint,
coupled with the strongest local knowledge to help drive clients' maximum
performance in every geography. Market-leading solutions ensure optimal
decisions and actions across the brand life cycle, from assessing
opportunities and sizing markets…to developing products and building access
strategies… to positioning brands and creating messaging…to managing
stakeholder relationships and monitoring treatment outcomes.

www.kantarhealth.com

Paula Paradise, Vice President, Global Marketing, paula.paradise at kantarhealth.com, +1-484-442-1431